NCT03340272|Unknown
PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.
PRO-EPI
Loading search results
PRO-EPI
Sponsor study identifier
observational
1,000
1 country
1
Study Start
February 21, 2017
Actual (reported)Primary Completion
February 21, 2020
Actual (reported)Study Completion
February 21, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The general aim of the study is to describe the use of elective pelvic node irradiation (ENI) in Italy, in patients with intermediate/high/very high-risk prostate cancer patients submitted to adjuvant or radical Radiation Therapy (RT) with or without concomitant Androgen Deprivation hormone Therapy (ADT). The study aims at the definition of survival, toxicity and QoL data in a representative sample of intermediate, high and very high risk prostate cancer patients consecutively recruited in Italian Radiation Oncology Center over two years.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 21, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 21, 2017
Actual (reported)October 30, 2017
Actual (reported)November 13, 2017
Actual (reported)February 21, 2020
Actual (reported)February 21, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Practice of pelvic irradiation
Evaluate the number of patients treated with RT on pelvic lymph-nodes in patients affected by intermediate/high/very high risk non-metastatic prostate cancer
Four months after the end of the enrollment
Radiotherapy techniques used for prostate cancer irradiation
Four months after the end of the enrollment
Outcome of treated prostate cancer
Three years after the end of the enrollment
Outcome of treated prostate cancer
Three years after the end of the enrollment
Outcome of treated prostate cancer
Three years after the end of the enrollment
Outcome of treated prostate cancer
Three years after the end of the enrollment
Patients treated for prostate cancer without or after surgery, with or without association of hormonal treatment.
University and Spedali Civili - Brescia
Brescia, 25123, Italy
Michela Buglione, Prof
University and Spedali Civili - Brescia
1,000 participants (actual enrollment reported by the registry).
First Submitted
October 30, 2017
First Posted
November 13, 2017
Study Start
February 21, 2017
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
February 21, 2020
Actual (reported)Study Completion
February 21, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 18, 2020
Record last verified: 2020-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: